KFSHRC Detects 276 Fetal Genetic Disorders Through Prenatal Care Saving SAR 360 Million Annually - Middle East Business News and Information
KFSHRC's Preventive Fetal Screening Program identifies genetic risks and ensures targeted care during critical pregnancy stages. Paired with technologies like Next-Generation Sequencing (NGS) and Non-Invasive Prenatal Testing (NIPT), these advancements enhance the precision and safety of prenatal diagnostics, benefiting 1,500 families annually. The Program has expanded its capacity to detect more than 500 additional genetic diseases, equipping families with early insights, reducing the birth of new-borns with severe genetic diseases, and improving overall offspring outcomes and well-being.
From screenings to therapeutic procedures and advanced surgical interventions, KFSHRC ensures well-being and trust remain at its core, shaping a healthier future for families. These efforts were recognised in 2023 when the prenatal department won a Performance Improvement Award for improving the patient experience through care accessibility and innovation.
It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15 th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
2 days ago
- Daily News Egypt
Egypt's Supreme Organ Transplant Committee strengthens oversight, standards
Egypt's Supreme Committee for Organ Transplantation convened to assess the country's transplant program, reinforce regulatory oversight, and align practices with international medical standards, the Ministry of Health announced Monday. Health Ministry spokesperson Hossam Abdel Ghaffar stated that the meeting addressed several key areas, including the formation of specialized subcommittees, strategies to counter misinformation on social media, and the introduction of a new regulation limiting transplant approval validity to one year. Under this regulation, each transplant program must be affiliated with a single licensed medical facility. According to 2024 data, the committee issued 1,614 transplant approvals—1,194 for kidneys and 420 for livers. That year, 1,271 transplants were performed: 764 kidney and 234 liver transplants for Egyptian patients, and 188 kidney and 85 liver transplants for non-Egyptians. So far in 2025, 907 approvals have been issued (677 kidney, 230 liver). Egypt currently has 40 licensed transplant centers operating across public, university, private, police, and military hospitals. In 2024, the committee renewed licenses for 14 liver and 18 kidney centers and approved five new hospitals under licensing decision No. 124. Random inspections of transplant facilities will continue, with immediate corrective actions enforced in cases of non-compliance. The committee also reviewed mortality and morbidity data and discussed the governance of transplant procedures. One notable case involved a 62-year-old father successfully donating a kidney to his son after the procedure was cleared under Cabinet Decree No. 74 of 2023 and in accordance with Egypt's Organ Transplant Law No. 5 of 2010. Officials highlighted the urgent need for updated legislation and tighter oversight to safeguard the rights of both donors and recipients. Established in 2023 under Decree No. 4497 and chaired by Minister of Health Dr. Khaled Abdel Ghaffar, the Supreme Committee includes leading medical figures, such as world-renowned heart surgeon Sir Magdi Yacoub. It is supported by dedicated scientific, ethical, and licensing subcommittees to ensure that Egypt's transplant practices meet global medical and ethical benchmarks.
Mid East Info
6 days ago
- Mid East Info
On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours - Middle East Business News and Information
Riyadh: King Faisal Specialist Hospital and Research Centre (KFSHRC) successfully performed 10 kidney exchange transplants over two consecutive days, setting a global record for the highest number of such procedures conducted within a two-day span at a single center, coinciding with World Organ Donation Day on August 13. This milestone reinforces KFSHRC's position as a global leader in organ transplantation. This accomplishment reflects the hospital's high clinical readiness, the seamless coordination of its multidisciplinary medical teams, and its advanced systems for managing donor-recipient matching, alongside its extensive experience in executing complex transplant procedures. All of these factors enable KFSHRC to carry out this type of exchange transplantation with precision and within an exceptionally short timeframe. Paired kidney transplantation is an innovative approach that matches donor–patient pairs for mutual exchange. In this system, each donor gives a kidney to a patient with whom they have no direct relation, while their own relative receives a kidney from another donor. The process significantly improves compatibility rates and offers new hope to patients who face challenges in finding a suitable match within their families. Last year, KFSHRC celebrated a major milestone by completing more than 500 paired kidney transplants since the program was launched in 2011. Since launching its organ transplantation program in 1981, the hospital has successfully performed over 5,000 kidney transplants, placing it among an elite group of global transplant centers. In 2024, the hospital conducted 80 pediatric kidney transplants, the highest annual volume reported worldwide. This makes KFSHRC's pediatric kidney transplant program the largest of its kind compared to leading centers in the United States and Europe. This remarkable achievement underscores KFSHRC's commitment to its vision of being the provider of choice for specialized healthcare. By leveraging its skilled workforce, advanced technologies, and the integration of research and clinical programs, the hospital aims to deliver world-class treatment experiences both locally and globally, while enhancing the Kingdom's position as a leader in organ transplantation. KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Mid East Info
04-08-2025
- Mid East Info
27-Year-Old Dubai Resident Successfully Treated for Rare Vein Condition at Aster Hospital Mankhool - Middle East Business News and Information
In a landmark medical achievement, Aster Hospital, Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025, successfully treated a young Dubai resident diagnosed with Superior Vena Cava Syndrome (SVCS), a rare and potentially life-threatening vein condition that blocks blood flow from the upper body back to the heart. Muhammad Bilal, a 27-year-old Pakistani national, had been suffering from symptoms of SVCS since 2020. His condition began with swelling on the right side of his face and neck, which gradually spread to involve his eye and the entire face, along with the appearance of a swollen vein over his abdominal area. In addition, he experienced shortness of breath, severe headaches, and visibly enlarged veins across his neck, chest, and abdomen. Initially painless, the swelling eventually became painful and distressing. Despite multiple consultations at various hospitals in the UAE and his home country, his condition remained undiagnosed and untreated until he visited Aster Cedar Hospital and was referred to Dr. Roshan Rodney S, Specialist Vascular and Endovascular Surgeon at Aster Hospital Mankhool. Upon clinical assessment and imaging scans, doctors confirmed a complete blockage in the superior vena cava—a major vein that carries blood from the upper body back to the heart. As a result, the body had started forming alternate blood flow channels to bypass the obstruction. To treat the blockage, Dr. Roshan and his team opted for a minimally invasive vein procedure, which is now the preferred treatment for SVCS due to its lower risk profile and rapid symptom relief. Using advanced imaging tools, they performed balloon angioplasty and placed a self-expanding stent to open the blocked vein and restore normal blood flow to the heart. Speaking on the severity of the patient's condition, the complexity of the procedure, and the positive outcome achieved through a coordinated team effort, Dr. Roshan Rodney S, Specialist Vascular and Endovascular Surgeon at Aster Hospital Mankhool, said, 'The vein was completely blocked, and the body had formed alternate routes to keep blood flowing. With the support of our anesthesia, cardiology, and ICU teams, we were able to restore blood flow seamlessly. The patient began to show significant symptom relief within hours of the procedure.' The results were immediate and remarkable. By the following day, the swelling in Muhammad Bilal's face had significantly reduced, and the prominent veins on his neck and abdomen had disappeared. He is now recovering well, with follow-up scans confirming the stent is working properly and his condition continues to improve. Muhammad Bilal expressed his gratitude, saying, 'I had been suffering for years, trying different hospitals and doctors, but no one could identify the problem. At Aster Hospital, I finally found answers. Dr. Roshan immediately diagnosed my condition and provided the treatment I had been waiting for. The swelling is gone, the pain has stopped, and I feel like I can live normally again. The care I received from the doctors, nurses, and staff made me feel like I was with family. I'm so thankful to be able to return to my regular life.' This case shines a light on the growing use of endovascular stenting in treating rare vein conditions and highlights the value of early diagnosis, modern imaging, and teamwork in managing complex health issues. SVCS is most commonly caused by cancers such as lung cancer or lymphoma, which can press on or grow into the vein, this happens in about 70% of cases[1]. In around 30% of cases, it's linked to long-term use of medical devices like central venous catheters or pacemakers, which can damage the vein walls over time.[2] A small number of cases (about 3–5%) are related to genetic clotting disorders, where repeated blood clots cause scarring and narrowing of the vein. [3] In extremely rare cases, such as Muhammad Bilal's, the cause remains unknown and is called idiopathic SVCS. For patients and families grappling with unexplained vein-related conditions, this successful case offers hope, showing how timely diagnosis and the right treatment can truly change lives This milestone reflects Aster Hospital Mankhool's dedication to pioneering care and improving patient outcomes through timely diagnosis and minimally invasive interventions.
